Phase 2 N=8 A Proof-of-Concept Trial on the Effect of Ketamine on Fatigue
Fatigue
Primary: Percentage Change in Self-reported Fatigue Visual Analog Scale (VAS) Scale — -21.0; -12.6 Percentage change
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=212 Intrapartum Maternal Oxygen Supplementation: Effects on the Mother and Neonate
Intrauterine Resuscitation
Primary: Umbilical Artery Malondialdehyde — 9.8; 10.2 umol/L
N/A N=182 The Psychosocial Effects of Systemic / Family Constellation
Mild to Moderate Psychopathological Symptoms
Primary: Change in General Severity Index Scores on the Brief Symptom Inventory — 0.82; 0.56; 0.58 score on a scale — p=<0.001
Phase 4 N=52 Impact of Statin Therapy on Adaptations to Aerobic Exercise
Cardiovascular Diseases
Primary: Difference in Mitochondrial Respiratory Function — 2.29; -11.24; 44.88 pmols/s/mg — p=0.9530
N/A N=42 Comparison of Bystander Fatigue and CPR Quality When Using Two Different CPR Ratios.
Cardiac Arrest
Primary: CPR Quality — 128.5; 126.6 count of chest compressions
N/A N=30 Effectiveness of Modified-free Gingival Graft for Treatment of Localized Gingival Recession Defects
Gingival Recession, Localized
Primary: Mean Mid-facial Recession Coverage (mRC) — 60.7; 91.8 percentage
N/A N=110 StandUPTV: Reducing Sedentary Screen Time in Adults
Sedentary Behavior · Screen Time · Physical Activity
Primary: Changes in Sedentary Screen Time — -88.2; -60.1; -102.7; -118.1 minutes per day
N/A N=80 The Effect of a Multivitamin in the Treatment of Memory Loss in Postmenopausal Women
Memory Disorders · Postmenopausal Symptoms
Primary: Change From Baseline of the Score Number Relative to the Self-efficacy Factor, Consisting of Average Scores on the Domains Capacity, Control and Change of the…
N/A N=638 SMART 2.0: Social Mobile Approaches to Reducing weighT in Young Adults
Overweight and Obesity
Primary: Change in Weight — -0.333; 0.737; 1.202 Kilograms
N/A N=293 Same Day Oral EC and Implant Initiation
Contraception
Primary: Pregnancy Rate at One-month — 1.96 percentage of participants
N/A N=687 PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy
Infection
Primary: Percentage of Subjects That Experienced Infection, Urinary Retention or Bleeding Requiring Intervention Within 7 Days of Biopsy Based on Transrectal Ultrasound Guided…
N/A N=1,013 Kids SipSmartER, an Intervention to Reduce Sugar-sweetened Beverages
Sugary Beverages
Primary: Student: SSB Change From Baseline to 7-months (All Participants) — -9.9; -2.7 fluid ounces
Phase 2 N=135 A Study to Determine the Safety and Immunogenicity of Bivalent GI.1 and GII.4 Vaccines in Healthy Volunteers
Norovirus Infections
Primary: Number of Participants With Solicited Symptoms of Reactogenicity (Gastrointestinal [GI] and Systemic) — 20; 20; 2; 9 Participants
N/A N=390 Income Volatility and Mental Health, Pilot Study
Depression
Primary: Depression — 7.4; 5.7; 6.3; 7.4 units on a scale
Phase 2 N=15 Calcium Channel Blockade in Primary Aldosteronism
Primary Aldosteronism · Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
Primary: Change in 24-hour Urinary Aldosterone Excretion Rate — 0.21 mcg/24h — p=0.96